These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 3103425)

  • 21. Factor VIII inhibitors in patients with hemophilia A.
    Oren H; Yaprak I; Irken G
    Acta Haematol; 1999; 102(1):42-6. PubMed ID: 10473887
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of the intron 22 inversion of the factor VIII gene and inhibitor development in Polish patients with severe hemophilia A.
    Sawecka J; Skulimowska J; Windyga J; Lopaciuk S; KoĊ›cielak J
    Arch Immunol Ther Exp (Warsz); 2005; 53(4):352-6. PubMed ID: 16088320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Haemophiliacs with factor VIII inhibitors in Finland: prevalence, incidence and outcome.
    Rasi V; Ikkala E
    Br J Haematol; 1990 Nov; 76(3):369-71. PubMed ID: 2124498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of patients with factor VIII inhibitors.
    Lusher JM
    Transfus Med Rev; 1987 Aug; 1(2):123-30. PubMed ID: 2980269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence of inhibitors in haemophiliacs. A review of the literature.
    Scharrer I; Neutzling O
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):753-8. PubMed ID: 8292725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cumulative inhibitor incidence in previously untreated patients with severe hemophilia A treated with plasma-derived versus recombinant factor VIII concentrates: a critical systematic review.
    Franchini M; Tagliaferri A; Mengoli C; Cruciani M
    Crit Rev Oncol Hematol; 2012 Jan; 81(1):82-93. PubMed ID: 21277222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of porcine factor VIII for surgical procedures in hemophilia A patients with inhibitors.
    Lozier JN; Santagostino E; Kasper CK; Teitel JM; Hay CR
    Semin Hematol; 1993 Apr; 30(2 Suppl 1):10-21. PubMed ID: 8480192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of plasma-derived factor VIII/von Willebrand factor concentrates in the treatment of hemophilia A patients.
    Auerswald G; Spranger T; Brackmann HH
    Haematologica; 2003 Jun; 88(6):EREP05. PubMed ID: 12826531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiology of inhibitors and current treatment strategies.
    Kreuz W; Ettingshausen CE; Auerswald G; Saguer IM; Becker S; Funk M; Heller C; Klarmann D; Klingebiel T;
    Haematologica; 2003 Jun; 88(6):EREP04. PubMed ID: 12826530
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibitors of factor VIII: detection and treatment.
    Brettler DB
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():21-5. PubMed ID: 7886576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitors in childhood hemophilia A: genetic and treatment-related risk factors for development and eradication.
    DiMichele DM
    Pediatr Blood Cancer; 2013; 60 Suppl 1():S30-3. PubMed ID: 23109404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factor VIII therapy for hemophilia A: current and future issues.
    Aledort L; Ljung R; Mann K; Pipe S
    Expert Rev Hematol; 2014 Jun; 7(3):373-85. PubMed ID: 24717090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibitor development in previously treated hemophilia A patients: a systematic review, meta-analysis, and meta-regression.
    Xi M; Makris M; Marcucci M; Santagostino E; Mannucci PM; Iorio A
    J Thromb Haemost; 2013 Sep; 11(9):1655-62. PubMed ID: 23802542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factor VIII inhibitors: a clinical overview.
    White GC; McMillan CW; Blatt PM; Roberts HR
    Am J Hematol; 1982 Dec; 13(4):335-42. PubMed ID: 6818857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of intraligamentary anesthesia in a patient with severe hemophilia and factor VIII inhibitor.
    Eigner TL
    Spec Care Dentist; 1990; 10(4):121-4. PubMed ID: 11100219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence of inhibitors in patients with severe and moderate hemophilia A treated with factor VIII concentrates.
    Schwarzinger I; Pabinger I; Korninger C; Haschke F; Kundi M; Niessner H; Lechner K
    Am J Hematol; 1987 Mar; 24(3):241-5. PubMed ID: 3103425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The incidence of factor VIII inhibitors in patients with severe hemophilia A.
    Hoyer LW
    Adv Exp Med Biol; 1995; 386():35-45. PubMed ID: 8851013
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.